Genetic diversity of human immunodeficiency virus in the Americas, with emphasis on the Venezuelan epidemics;Diversidad genética del virus de inmunodeficiencia humana en las Américas, con énfasis en la epidemia Venezolana

Interciencia

Volumn 34, Issue 3, 2009, Pages 163-169

  Rangel, Héctor R ^a,b   Garzaro, Domingo ^a,c   Pujol, Flor H ^b,d,e  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Instituto Venezolano de Investigaciones Científcas IVIC   (Venezuela)

^c INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^d UNIVERSIDAD SIMÓN BOLÍVAR   (Venezuela)

^e Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 67650789319     PISSN: 03781844     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Aguayo N, Laguna-Torres VA, Villafañe M, Bar-boza A, Sosa L, Chauca G, Carrión G, Co-enca B, Pérez J, Galeano A, Bautista CT, Sánchez JL, Carr JK, Kochel T (2008) Epi-demiological and molecular characteristics of HIV-1 infection among female commercial sex workers, men who have sex with men and people living with AIDS in Paraguay. Rev. Soc. Bras. Med. Trop. 41: 225-231.
2. Akouamba BS, Viel J, Charest H, Merindol N, Samson J, Lapointe N, Brenner BG, Lalonde R, Harrigan PH, Boucher M, Soudeyns H (2005) HIV-1 genetic diversity in antenatal cohort, Canada. Emerg. Infect. Dis. 11: 1230-1234
3. de Arazoza H, Joanes J, Lounes R, Legeai C, Clémençon S, Pérez J, Auvert B (2007) The HIV/AIDS epidemic in Cuba: description and tentative explanation of its low HIV prevalence. BMC Infect. Dis. 7: 130.
4. Aulicino PC, Holmes EC, Rocco C, Mangano A, Sen L (2007a) Extremely rapid spread of human immunodefciency virus type 1 BF recom-binants in Argentina. J. Virol. 81: 427-429.
5. Aulicino PC, Bello G, Rocco C, Romero H, Man-gano A, Morgado MG, Sen L (2007b) Description of the frst full-length HIV type 1 subtype F1 strain in Argentina: implications for the origin and dispersion of this subtype in South America. AIDS Res. Hum. Retrov. 23: 1176-1182.
6. Ávila MM, Pando MA, Carrión G, Peralta LM, Salomón H, Carrillo MG, Sánchez J, Maulen S, Hierholzer J, Marinello M, Negrete M, Russell KL, Carr JK (2002) Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J. Acquir. Immune Defc. Syndr. 29: 422-426.
7. Bastos FI, Cáceres C, Galvão J, Veras MA, Cas-tilho EA (2008) AIDS in Latin America: assessing the current status of the epidemic and the ongoing response. Int. J. Epidemiol. 37: 7 2 9-7 3 7.
8. Bayer R, Healton C (1989) Controlling AIDS in Cuba. The logic of quarantine. N. Engl. J. Med. 320: 1022-1024.
9. Bello G, Eyer-Sylva WA, Couto-Fernández JC, Guimarães ML, Chequer-Fernández SL, Teixeira SL, Morgado MG (2007) Demographic history of HIV-1 subtypes B and F in Brazil. Infect. Genet. Evol. 7: 263-270.
10. Bello G, Passães CP, Guimarães ML, Lorete RS, Matos Almeida SE, Medeiros RM, Alencas-tro PR, Morgado MG (2008) Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS 22: 1993-2000.
11. Bouchard M, Masquelier B, Moreno M, Deibis L, de Pérez GE, Fleury H, Castro E (2007) HIV type 1 drug resistance among native patients from Venezuela. AIDS Res. Hum. Ret-rov. 23: 482-485
12. Brander C, Frahm N, Walker B (2006) The challenges of host and viral diversity in HIV vaccine design. Curr. Opin. Immunol. 18: 430-437.
13. Brodine SK, Starkey MJ, Shaffer RA, Ito SI, Tasker SA, Barile AJ, Tamminga CL, Steph-an KT, Aronson NE, Fraser SL, Wallace MR, Wegner SA, Mascola JR, McCutchan FE (2003) Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort. AIDS 17: 2521-2527.
14. Buonaguro L, Tornesello ML, Buonaguro FM (2007) Human immunodefciency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J. Virol. 81: 10209-10219.
15. Carr JK, Ávila M, Gómez-Carrillo M, Salomón H, Hierholzer J, Watanaveeradej V, Pando MA, Negrete M, Russell KL, Sánchez J, Birx DL, Andrade R, Viñoles J, McCutchan FE (2001) Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 15: F41-F47.
16. Casado G, Thomson MM, Sierra M, Nájera R (2005) Identifcation of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19-cpx) in Cuba. J. Acquir. Immune Defc. Syndr. 40: 532-537.
17. Castro E, Echeverría G, Deibis L, González de Salmen B, Dos Santos Moreira A, Guimarães ML, Bastos FI, Morgado MG (2003) Molecular Epidemiology of HIV-1 Infection in Venezuela: high prevalence of HIV-1 subtype B and identifcation of a B/F recombinant infection. J. Acquir. Immune Defc. Syndr. 3: 338-344.
18. Castro E, Moreno M, Deibis L, de Pérez G, Sal-men S, Berrueta L (2005) Trends of HIV-1 molecular epidemiology in Venezuela: introduction of subtype C and identifcation of a novel B/C mosaic genome. J. Clin. Virol. 32: 257-258.
19. Cleghorn FR, Jack N, Carr JK, Edwards J, Ma-habir B, Sill A, McDanal CB, Connolly SM, Goodman D, Bennetts RQ, O'Brien TR, Weinhold KJ, Bartholomew C, Blattner WA, Greenberg ML (2000) A distinctive clade B HIV type is heterosexually transmitted in Trinidad and Tobago. Proc. Natl. Acad. Sci. USA 97: 10532-10537.
20. Delgado E, León-Ponte M, Villahermosa ML, Cuevas MT, Deibis L, Echeverría G, Thomson MM, Pérez-Álvarez L, Osmanov S, Nájera R (2001) Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classifcation: a UNAIDS study. AIDS Res. Hum. Retrov. 17: 753-758.
21. Delwart EL, Orton S, Parekh B, Dobbs T, Clark K, Busch MP (2003) Two percent of HIV-positive US. Blood donors are infected with non-subtype B strain. AIDS Res. Hum. Retrov. 19: 1065-1070.
22. Dieudonné M, Garzaro D, Torres J, Naranjo L, Suárez JA, Castro J, Martínez N, Castro E, Berrueta L, Salmen S, Devesa M, Rangel HR, Pujol FH (2006) High prevalence of secondary resistance mutations in Venezuelan HIV-1 isolates. Invest. Clin. 47: 27-34.
23. Dilernia DA, Gómez AM, Lourtau L, Marone R, Losso MH, Salomón H, Gómez-Carrillo M (2007) HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina. AIDS Res. Hum. Retrov. 23: 1201-1207.
24. Epsteins F (1993) The immunoptogenesis of Human Immunodefciency virus infection. N. Eng. J. Med. 328: 327-335.
25. Eyer-Silva WA, Couto-Fernández JC, Morgado MG (2007) Molecular Epidemiology of HIV-1 in inner Río de Janeiro state, Brazil. AIDS Res. Hum. Retrov. 23: 303-308.
26. Eyzaguirre L, Bautista CT, Ayala C, Acosta J, Negrete M, Saturen WB, Montano SM, Sánchez JL, Carr JK (2006) First Case of HIV type 1 subtype F among men who have sex with men in Colombia. AIDS Res. Hum. Retrov. 22: 808-811.
27. Eyzaguirre L, Brouwer KC, Nadal y, Patterson TL, Ramos R, Firestone Cruz M, Orozovich P, Strathdee SA, Carr JK (2007) First molecular surveillance report of HIV type 1 in injecting drug user and female sex workers along the U.S.-Mexico border. AIDS Res. Hum. Retrov. 23: 331-334.
28. Foley B, Pan H, Buchbinder S, Del Wart EL (2000) Apparent founder effect during the early years of the San Francisco HIV type 1 epidemic (1978-1979). AIDS Res. Hum. Retrov. 16: 1463-14 69.
29. Fonseca MG, Bastos FL (2007) Twenty-fve years of the AIDS epidemic in Brazil: principal epidemiological fndings, 1980-2005. Cad. Saude Publ. 23: S333-S344.
30. Fusuma EE, Caruso SC, López DF, Costa LJ, Ja-nini LM, De Mendonça JS, Kallas EG, Díaz RS (2005) Duplication of peri-kappaB and NF-kappab sites of the frst human immuno-defciency virus type 2 (HIV-2) transmission in Brazil. AIDS Res. Hum. Retrov. 21: 965-970.
31. Gayle HD, Hill GL (2001) Global impact of human immunodefciency virus and AIDS. Clin. Microbiol. Rev. 14: 327-335.
32. Geretti AM (2006) HIV-1 subtypes: epidemiology and signifcance for HIV management. Curr. Opin. Infect. Dis. 19: 1-7.
33. Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M (2007) The emergence of HIV/AIDS in the Americas and beyond. Proc. Natl. Acad. Sci. USA 104: 18566-18570.
34. Gittens M V, Roth WW, Roach T, Stringer HG Jr, Pieniazek D, Bond VC, Levett PN (2003) The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados. AIDS Res. Hum. Retrov. 19: 313-319.
35. Gómez-Carrillo M, Pampuro S, Durán A, Losso M, Harris DR, Read JS, Duarte G, De Souza R, Soto-Ramírez L, Salomón H; NISDI Perinatal Study Group (2006) Analysis of HIV type 1 diversity in pregnant women from four Latin American and Caribbean countries. AIDS Res. Hum. Retrov. 22: 1186-1191.
36. Guimarães ML, Bastos FI, Telles PR, Galvão-Castro B, Díaz RS, Bongertz V, Morgado MG (2001) Retrovirus infection in a sample of injecting drug user in Río de Janeiro city, Brazil: prevalence of HIV-1 subtypes and co-infection with HTLV-I/II. J. Clin. Virol. 21: 143-151.
37. Hacker MA, Malta M, Enríquez M, Bastos FI (2005) Human immunodefciency virus, AIDS, and drug consumption in South America and the Caribbean: epidemiological evidence and initiatives to curb the epidemic. Rev. Panam. Salud Publ. 18: 303-313.
38. Heslop OD, Smikle MF, Deed D, Christian NA, Vickers IE, Harvey KM, Figueroa JP, Christie CDC, Bain B, Barton EN (2005) Human Immunodefciency virus type-1 (HIV-1) subtypes in Jamaica. West Indian Med. J. 54: 279-282.
39. Hierholzer J, Montano S, Hoelscher M, Negrete M, Hierholzer M, Ávila MM, Carrillo MG, Russi JC, Viñoles J, Alava A, Acosta ME, Gianella A, Andrade R, Sánchez JL, Carrión G, Sánchez JL, Russell K, Robb M, Birx D, McCutchan F, Carr JK (2002) Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina. AIDS Res. Hum. Retrov. 18: 1339-1350.
40. Jayaraman GC, Gleeson T, Rekart ML, Cook D, Preiksaitis J, Sidaway F, Harmen S, Dawood M, Wood M, Ratnam S, Sandstrom P, Archibald C (2003) Prevalence and determinants of HIV-1 subtypes in Canada: enhancing routinely collected information through the Canadian HIV Strain and Drug Resistance Surveillance Program. Can. Commun. Dis. Rep. 29: 29-36.
41. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, Eller LA, Eller M, Makumbi F, Birx D, Wabwire-Mangen F, Serwadda D, Sewankambo NK, Quinn TC, Wawer M, Gray R (2008) Effect of human immunodefciency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J. Infect. Dis. 197: 70 7-113.
42. Kuiken C, Thakallapalli R, Eskild A, de Ronde A (2000) Genetic analysis reveals epidemio-logic patterns in the spread of human immu-nodefciency virus. Am. J. Epidemiol. 152: 814-822 .
43. Kuritzkes DR (2008) HIV-1 Subtype as a Determinant of Disease Progression. J. Infect. Dis. 197: 638-639.
44. Lloyd B, O'Connell RJ, Michael NL, Avilés R, Palou E, Hernández R, Cooley J, Jagodzinski LL (2008) Prevalence of resistance mutations in HIV-1-Infected Hondurans at the beginning of the National Antiretroviral Therapy Program. AIDS Res. Hum. Retrov. 24: 529-535.
45. Montano SM, Sánchez JL, Laguna-Torres A, Cuchi P, Ávila MM, Weissenbacher M, Serra M, Viñoles J, Russi JC, Aguayo N, Galeano AH, Gianella A, Andrade R, Arredondo A, Ramírez E, Acosta ME, Alava A, Montoya O, Guevara A, Manrique H, Sánchez JL, Lama JR, de la Hoz F, Sánchez GI, Ayala C, Pacheco ME, Carrión G, Chauca G, Pérez JJ, Negrete M, Russell KL, Bautista CT, Olson JG, Watts DM, Birx DL, Carr JK; for the South American HIV Molecular Surveillance Working Group (2005) Prevalences, genotypes, and risk factors for HIV transmission in South America. J. Acquir. Immune Defc. Syndr. 40: 57-64.
46. MSDS de Venezuela (2005) Declaración de com-promiso en la lucha contra el VIH/SIDA. UNGASS 2001: Informe del Gobierno de laRepública Bolivariana de Venezuela, Periodo 2003-2005. Ministerio de Salud y Desarrollo Social. Caracas, Venezuela.
47. Noel RJ Jr, Chaudhary S, Rodríguez N, Kumar A, yamamura y (2003) Phylogenetic Relationships between Puerto Rico and continental USA HIV-1 pol sequences: a shared HIV-1 infection. Cell. Mol. Biol. 49: 1193-1198.
48. ONUSIDA (2007) Situación de la Epidemia de Sida. www.data.unaids.org/pub/EPISlides/2007/ 2007-epiupdate-es.pdf
49. Pando MA, De Salvo C, Bautista CT, Eyzaguirre L, Carrión G, Feola M, Lado I, Hoffman M, Biglione MM, Carr JK, Montano SM, Sán-chez JL, Weissenbacher M, Ávila MM (2008) Human immunodefciency virus and tuberculosis in Argentina: prevalence, genotypes and risk factors. J. Med. Microbiol. 57: 190-197.
50. Peeters M, Toure-Kane C, Nkengasong JN (2003) Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. AIDS 17:2547-2560.
51. Pérez L, Thomson MM, Bleda MJ, Aragonés C, González Z, Pérez J, Sierra M, Casado G, Delgado E, Nájera R (2006) HIV Type 1 molecular epidemiology in Cuba: high genetic diversity, frequent mosaicism, and recent expansion of BG intersubtype recombi-nant forms. AIDS Res. Hum. Retrov. 22: 724-733.
52. Pérez-Stable EJ (1991) Cuba's response to the HIV epidemic. Am. J. Public Health 81: 563-5 6 7.
53. Pierre JA, Fournier AM (1999) Human immunodefciency virus infection in Haiti. J. Natl. Med. Assoc. 91: 165-170.
54. Pujol FH (2006) Virus en primates no humanos: zoonosis, antroponosis y biodiversidad. Inter-ciencia 31: 396-402.
55. Quinn TC (1995) The epidemiology of the acquired immunodefciency syndrome in the 1990s. Emerg. Med. Clin. North Am. 13: 1-25.
56. Quiñones-Mateu ME, Dopazo J, Esté JA, Rota TR, Domingo E (1995) Molecular characterization of human immunodefciency virus type 1 isolates from Venezuela. AIDS Res. Hum. Retrov. 11: 605-616.
57. Rangel HR, Garzaro DJ, Gutiérrez CR, Vásquez L, Guillén G, Torres JR, Pujol FH (2009) HIV diversity in Venezuela: predominance of HIV-1 subtype B and genomic characterization of non B variants. AIDS Res. Hum. Retroviruses. En prensa.
58. Reeves JD, Doms RW (2002) Human immunode-fciency virus type 2. J. Gen. Virol. 83: 1253-1265.
59. Requejo HI (2006) Worldwide molecular epidemiology of HIV-1. Rev. Saude Publica 40: 331-345.
60. Ríos M, Fernández J, Jaramillo P, Paredes V, Sánchez JL, Laguna-Torres VA , Carr JK, Ramírez E (2005) Molecular epidemiology of HIV type 1 in Chile: differential geographic and transmission route distribution of B and F subtypes. AIDS Res. Hum. Retrov. 21: 835-840.
61. Ríos M, Delgado E, Pérez-Álvarez L, Fernández J, Gálvez P, de Parga EV, yung V, Thomson MM, Nájera R (2007) Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile. J. Med. Virol. 79: 647-656.
62. Rivera-Morales LG, Novitsky VA , Trujillo JR, Lavalle-Montalvo C, Cano-Domonguez C, Ramos-Jiménez J, Jiménez-Ríos E, Flores-Flores L, López-Guillén P, Gilbert P, Vann- berg F, Taámez-Guerra R, Rodríguez-Padilla C, Essex M (2001) The molecular epidemiology of HIV-1 of men in Mexico. AIDS Res. Hum. Retrov. 17:87-92.
63. Robbins KE, Lemey P, Pybus OG, Jaffe HW, youngpairoj AS, Brown TM, Salemi M, Vandamme AM, Kalish ML (2003) U.S. Human immunodefciency virus type 1 epidemic: date of origin, population history, and characterization of early strains. J. Virol. 77: 6359-6366.
64. Rodríguez CM, Marques LF, Touzé G (2002) HIV and injection drug use in Latin America. AIDS 16: S34-S41.
65. Russell KL, Cárcamo C, Watts DM, Sánchez J, Gotuzzo E, Euler A, Blanco JC, Galeano A, Alava A, Mullins JI, Holmes KK, Carr JK (2000) Emerging genetic diversity of HIV-1 in South America. AIDS 14: 1785-1791.
66. Sá-Ferreira JA, Álvarez Brindeiro P, Chequer- Fernández S, Tanuri A, Morgado MG (2007) Human immunodefciency virus-1 subtypes and antiretroviral drug resistance profles among drug-native Brazilian blood donors. Transfusion 47: 87-102.
67. Sánchez GI, Bautista CT, Eyzaguirre L, Carrión G, Arias S, Sateren WB, Negrete M, Monta-no SM, Sánchez JL, Carr JK (2006) Molecular epidemiology of human immunodefciency virus-infected individuals in Medellin, Colombia. Am. J. Trop. Med. Hyg. 74: 674-677.
68. Santos AF, Sousa TM, Soães EA, Sanabani S, Martínez AM, Sprinz E, Silveira J, Sabino EC, Tanuri A, Soãres MA (2006) Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil. AIDS 20: 2011-2019.
69. Sepkowitz KA (2006) One disease, two epidemics, AIDS at 25. N. Eng. J. Med. 354: 2411-2 414.
70. Sierra M, Thomson MM, Posada D, Pérez L, Aragonés C, González Z, Pérez J, Casado G, Nájera R (2007) Identifcation of 3 phyloge-netically related HIV-1 BG intersubtype circulating recombinant forms in Cuba. J. Ac-quir. Immune Defc. Syndr. 45: 151-160.
71. Taylor MS, Sobieszczyk ME, McCutchan FE, Hammer SM (2008) The challenge of HIV-1 subtype diversity. N. Eng. J. Med. 358: 1590-1602.
72. Tebit DM, Nankya I, Arts EJ, Gao y (2007) HIV diversity, recombination and disease progression: how does ftness "fit" into the puzzle? AIDS Rev. 9: 75-8 7.
73. Thomson MM, Nájera R (2001) Travel and the Introduction of Human Immunodefciency Virus Type 1 Non-B Subtype Genetic Forms into Western Countries. Travel Med. 32: 1732-1737.
74. Thomson MM, Casado G, Posada D, Sierra M, Nájera R (2005) Identifcation of a novel HIV-1 complex circulating recombinant form (CRF18-cpx) of Central African origin in Cuba. AIDS 19: 1155-1163.
75. Torres JR, Torres-Viera MA, Schupbach J, Ran-gel HR, Pujol FH (2007) Non-immune thrombocytopenia responsive to antiretrovi-ral therapy and HIV-2 infection. J. Infect. 54: e21-e24.
76. Tovanabutra S, Brodine SK, Mascota JR, Sankale JL, Sanders-Buell E, Kim B, Birx DL, McCutchan FE (2005) Characterization of complete HIV type 1 genomes from non-B subtype infection in U.S. military personnel. Aids Res Hum Retrov. 21:424-429.
77. Vaughan HE, Cane P, Pillay D, Tender RS (2003) Characterization of HIV type clades in the Caribbean using pol gene sequences. AIDS Res. Hum. Retrov. 19: 929-932.
78. Veras NMC, Veras VS, Ramalho ED, Kyat C, Silva RR, Brigido MM, Martins CRF (2007) HIV Type 1 genetic varibility in central Brazil. AIDS Res. Hum. Retrov. 23: 1481-1489.
79. Viñoles J, Serra M, Russi JC, Ruchansky D, So-sa-Estani S, Montano SM, Carrión G, Eyza-guirre LM, Carr JK, Olson JG, Bautista CT, Sánchez JL, Weissenbacher M (2005) Seroin-cidence and phylogeny of human immunode-fciency virus infections in a cohort of commercial sex workers in Montevideo, Uruguay. Am. J. Trop. Med. Hyg. 72: 495-500.
80. Weidle PJ, Ganea CE, Irwin KL, Pieniazek D, McGowan JP, Olivo N, Ramos A, Lal RB, Holmberg SD, Ernst JA (2000) Presence of human immunodefciency virus (HIV) type 1, group M, non-B subtypes, Bronx, New york: a sentinel site for monitoring HIV genetic diversity in the United States. J. Infect. Dis. 181: 470-475.